Life after womb cancer

  • Research type

    Research Study

  • Full title

    The impact of womb cancer diagnosis on long-term health

  • IRAS ID

    320713

  • Contact name

    Esther Moss

  • Contact email

    em321@le.ac.uk

  • Sponsor organisation

    University of Leicester

  • Duration of Study in the UK

    1 years, 11 months, 25 days

  • Research summary

    The most common risk factors for womb cancer are obesity and physical inactivity. Many physical activity and weight loss interventions have been designed for individuals who have completed womb cancer treatment, however, many of the expectations of the intervention, for example volume of physical activity or target amount of weight loss, are viewed as not realistically achievable. As a result the uptake of such interventions is very low, typically <20% of the EC population, and particularly low in the elderly womb cancer population. In order to design an intervention that will have greater impact in this population, the first step is to understand the real-world experiences/challenges of weight loss strategies and activity levels of womb cancer survivors.
    This study will recruit participants who have undergone primary treatment for low-risk womb cancer in the previous 6 months. Participants will be recruited through their usual care team at the University Hospitals of Leicester. Patients will be invited to participate in a semi-structured telephone interview that will ask them about their recovery from womb cancer treatment, their general health, diet/weight, and physical activity levels. The key survivorship challenges experienced following womb cancer treatment, such as pain, bladder and bowel symptoms will be explored. Participants’ views on weight loss interventions, such as low-calorie diets and medication, will also be discussed. At the end of the questionnaire the participants will be asked to put on a wrist-watch physical activity monitor that will have been sent to them in the post, in order to capture their physical activity and sleep levels for 1 week. After 8 days the participants will be instructed to return the monitor to the research team.

  • REC name

    Wales REC 3

  • REC reference

    22/WA/0330

  • Date of REC Opinion

    15 Nov 2022

  • REC opinion

    Favourable Opinion